Catalyst Pharmaceuticals, Inc. ( NASDAQ:CPRX – Get Rating ) shares shot up 6.2% during mid-day trading on Wednesday after Piper Sandler raised their price target on the stock from $21.00 to $24.00. The company traded as high as $13.45 and last traded at $13.40. 1,873,714 shares traded hands during mid-day trading, a decline of 14% from the average session volume of 2,177,091 shares. The stock had previously closed at $12.62. CPRX has been the subject of a number of other research reports. StockNews.

https://www.dailypolitical.com/2023/06/21/catalyst-pharmaceuticals-nasdaqcprx-trading-6-2-higher-following-analyst-upgrade.html

#dailypolitical